![]() |
市场调查报告书
商品编码
1819746
2021-2031 年欧洲医学写作市场报告(范围、细分、动态和竞争分析)Europe Medical Writing Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
欧洲医学写作市场预计将大幅成长,预计到 2031 年将达到约 27.2901 亿美元,高于 2023 年的 11.9687 亿美元。这一成长轨迹反映了 2023 年至 2031 年 10.9% 的年复合成长率(CAGR)。
执行摘要和市场分析
欧洲医学写作产业正在强劲扩张,主要原因是临床试验、监管申报和科学出版物对高品质文件的需求日益增长。在各个细分领域中,临床写作仍然是最大的市场,而在全球监管框架日益复杂的推动下,监管写作正迅速成为成长最快的领域。受惠于在研发方面的大量投资,德国目前是欧洲医学写作市场的领导者。预计英国将在不久的将来实现最高的成长率。该市场的主要参与者包括 Parexel、Certara、Covance 和 Quanticate 等。此外,人工智慧 (AI) 与医学写作流程的整合日益受到关注,显着提高了文件准备的效率和准确性。
市场区隔分析
医学写作市场可以根据类型、应用和最终用户进行细分。
市场展望
与业务流程外包 (BPO) 公司相比,CRO 的医学撰稿人撰写的文件品质通常被认为更高。 CRO 通常提供深入的科学资料,在格式、呈现方式和合规性方面均表现出色。此外,CRO 以准时完成截止日期而闻名,这在快节奏的临床试验和监管提交环境中至关重要。
CRO 的技术实力也备受认可,使其成为医学写作外包的首选。 Makro Care 等大型 CRO 已在欧洲多个城市设立分支机构,这提升了製药和生物技术公司与其合作的舒适度。凭藉其技术专长和地理覆盖范围,CRO 成为医学写作专案外包的首选。
国家洞察
欧洲医学写作市场涵盖几个主要国家,包括德国、法国、义大利、西班牙、英国和其他欧洲国家。截至2023年,德国占最大的市场份额。
德国医学写作市场的成长主要归功于该国强大的製药和生物技术行业,这些行业需要专门的临床试验、监管提交和科学出版物相关文件。德国有两个监管机构:联邦药品和医疗器材研究所(负责监管涉及药品和医疗器材的临床试验)和保罗·埃尔利希研究所(PEI),后者负责疫苗和体细胞疗法。德国的医学写作人员确保其文件符合所有关于内容、格式和结构的相关法规和指南。
德国拥有拜耳和勃林格殷格翰等大型製药公司,这进一步推动了对监管提交、临床试验和行销材料中高品质医学写作的需求。欧洲药品管理局 (EMA) 和德国联邦药品和医疗器材研究所 (BfArM) 等机构制定的严格监管要求对准确、高品质的医学写作至关重要。德国临床试验数量的增加,尤其是在肿瘤学和罕见疾病领域,为熟练的医学作家创造了更多的职业机会。此外,外包医学写作服务以降低成本和获得专业知识的趋势正在上升。德国着名的市场参与者,包括 Parexel、Covance 和 IQVIA,为各个治疗领域提供全面的写作服务。用于监管提交和试验管理的创新软体工具的引入也提高了医学写作流程的效率,促进了德国市场的持续成长。
公司简介
欧洲医学写作市场的主要参与者包括 Cactus Communications、Parexel International Corp、Certara Inc.、Freyr LLC、Quanticate International Ltd、SIRO Clinpharm Pvt Ltd、ProPharma Group、Caidya、Wipro Ltd、SGS SA、Laboratory Corp of America Holdings、TUNECT、Indegene Ltd、Evidera、SGS- SA、Laboratory Corp of America Holdings、TUNECT、Indegenea Ltd、Evidera、SEM-G」表、Ojptics Biovplates、Tirform、TTrap、Evidera、SEM-GTamp、Tirak) Consultancy Services Ltd、InClin 和 TransPerfect Life Sciences 等。这些公司正在采用各种策略,包括扩张、产品创新和併购,以提升其市场影响力并为客户提供创新解决方案。
The European medical writing market is poised for substantial growth, with projections indicating it will reach approximately USD 2,729.01 million by 2031, up from USD 1,196.87 million in 2023. This growth trajectory reflects a compound annual growth rate (CAGR) of 10.9% from 2023 to 2031.
Executive Summary and Market Analysis
The medical writing sector in Europe is witnessing a robust expansion, primarily fueled by the rising need for high-quality documentation in clinical trials, regulatory submissions, and scientific publications. Among the various segments, clinical writing remains the largest, while regulatory writing is rapidly emerging as the fastest-growing segment, driven by the increasing complexity of global regulatory frameworks. Germany is currently the leader in the European medical writing market, benefiting from significant investments in research and development. The United Kingdom is anticipated to experience the highest growth rate in the near future. Key players in this market include Parexel, Certara, Covance, and Quanticate, among others. Furthermore, the integration of artificial intelligence (AI) into medical writing processes is gaining traction, significantly improving the efficiency and accuracy of document preparation.
Market Segmentation Analysis
The medical writing market can be segmented based on type, application, and end user.
Market Outlook
The quality of documents produced by medical writers in CROs is often regarded as superior compared to those from business process outsourcing (BPO) companies. CROs typically provide in-depth scientific data, excelling in formatting, presentation, and adherence to regulatory guidelines. Additionally, CROs are known for their punctuality in meeting deadlines, which is crucial in the fast-paced environment of clinical trials and regulatory submissions.
CROs are also recognized for their technological proficiency, making them a preferred choice for outsourcing medical writing tasks. Major CROs, such as Makro Care, have established a presence across various European cities, which enhances the comfort level of pharmaceutical and biotechnology companies when collaborating with them. The combination of technical expertise and geographic reach positions CROs as the first choice for outsourcing medical writing projects.
Country Insights
The European medical writing market encompasses several key countries, including Germany, France, Italy, Spain, the UK, and other European nations. Germany holds the largest market share as of 2023.
The growth of the medical writing market in Germany is largely attributed to the country's strong pharmaceutical and biotechnology sectors, which necessitate specialized documentation for clinical trials, regulatory submissions, and scientific publications. Germany is home to two regulatory authorities: the Federal Institute for Drugs and Medical Devices, which oversees clinical trials involving drugs and medical devices, and the Paul Ehrlich Institute (PEI), which is responsible for vaccines and somatic cell therapy. Medical writers in Germany ensure that their documents comply with all relevant regulations and guidelines regarding content, format, and structure.
Germany hosts major pharmaceutical companies, such as Bayer and Boehringer Ingelheim, which further drives the demand for high-quality medical writing in regulatory submissions, clinical trials, and marketing materials. The stringent regulatory requirements set by agencies like the European Medicines Agency (EMA) and the Federal Institute for Drugs and Medical Devices (BfArM) necessitate accurate and high-quality medical writing. The increasing number of clinical trials in Germany, particularly in oncology and rare diseases, is creating more career opportunities for skilled medical writers. Additionally, the trend of outsourcing medical writing services to reduce costs and access specialized expertise is on the rise. Prominent market players in Germany, including Parexel, Covance, and IQVIA, offer comprehensive writing services across various therapeutic areas. The introduction of innovative software tools for regulatory submissions and trial management is also enhancing the efficiency of medical writing processes, contributing to the ongoing growth of the market in Germany.
Company Profiles
Key players in the European medical writing market include Cactus Communications, Parexel International Corp, Certara Inc., Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, and TransPerfect Life Sciences, among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to their clients.